Ixekizumab trough concentrations in psoriasis: Paving the way towards personalised therapy: A cohort study
Abstract Background Biologics for psoriasis demonstrate varying clinical outcome in real‐world practice, implying potential under‐ and overexposure. Objectives In this prospective cohort study we aimed to develop and validate an in‐house sandwich‐type enzyme‐linked immunosorbent assay (ELISA) for ix...
Saved in:
| Main Authors: | Lisa Schots, Rani Soenen, Debby Thomas, Annelies Stockman, Erwin Dreesen, Anke Eylenbosch, Jo Lambert |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | JEADV Clinical Practice |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jvc2.491 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ixekizumab: an alternative for HIV-positive psoriasis patients
by: Fanghua Liu, et al.
Published: (2024-11-01) -
Successful Treatment of Linear Psoriasis With the IL-17a-Antagonist Ixekizumab: A Case Report
by: Christov S, et al.
Published: (2025-01-01) -
Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events
by: Mark Lebwohl, et al.
Published: (2025-01-01) -
Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsy
by: Shota Kaburaki, et al.
Published: (2024-12-01) -
Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab
by: A. Egeberg, et al.
Published: (2022-07-01)